$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺(MDV 3100)中国进医保了没?
2025-10-19 11:44:20
Check Details
恩杂鲁胺国内在医保目录中吗?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)在国内的上市日期
2025-10-19 11:44:20
Check Details
恩杂鲁胺在国内怎样购买?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)有哪些优势呢?
2025-10-19 11:44:20
Check Details
用恩杂鲁胺大概多久会出现耐药情况?
2025-10-19 11:44:20
Check Details
恩杂鲁胺该如何用呢?
2025-10-19 11:44:20
Check Details
国内该如何买恩杂鲁胺?
2025-10-19 11:44:20
Check Details
恩杂鲁胺治疗期间应注意什么呢?
2025-10-19 11:44:20
Check Details
泽珂的治疗效果如何?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)入医保了没呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺规格跟价格
2025-10-19 11:44:20
Check Details
1
2
...
1412
1413
1414
1415
1416
1417
1418
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
2
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
3
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
4
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
5
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
6
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
7
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
8
Eltrombopag Administration Timing and Alternative Therapy Guide
9
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
10
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
11
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
12
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies